← SearchSLCO2B1 AND SLCO1B3 AS NEW TARGETS FOR ENHANCING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER$648,750FY2014Department of the ArmyDODDana-Farber Cancer Institute, Inc.InvestigatorsView source on USAspending →